Sfoglia per Autore
Relevance of the vascular effects of insulin in the rationale of its therapeutical use
2007-01-01 Anfossi G; Russo I; Doronzo G; Trovati M.
Pathophysiology of platelet resistance to anti-aggregating agents in insulin resistance and type 2 diabetes: implications for anti-aggregating therapy
2006-01-01 G. ANFOSSI; M. TROVATI
Sodium azide in commercially available C-reactive protein preparations does not influence matrix metalloproteinase-2 synthesis and release in cultured human aortic vascular smooth muscle cells
2006-01-01 DORONZO G; RUSSO I; TROVATI M; ANFOSSI G.
Platelet resistance to the anti-aggregating agents in the insulin resistant states.
2006-01-01 ANFOSSI G; RUSSO I; M. TROVATI
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study
2006-01-01 CAVALOT F; PETRELLI A; TRAVERSA M; BONOMO K; FIORA E; CONTI M; ANFOSSI G; COSTA G; TROVATI M
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling
2006-01-01 DORONZO G; RUSSO I; MATTIELLO L; RIGANTI C; ANFOSSI G; TROVATI M
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism
2005-01-01 MASSUCCO P; MATTIELLO L; RUSSO I; TRAVERSA M; DORONZO G; ANFOSSI G; TROVATI M
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways
2005-01-01 DORONZO G; RUSSO I; MATTIELLO L; TROVATI M; ANFOSSI G.
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells
2005-01-01 DORONZO G; RUSSO I; MATTIELLO L; TROVATI M; ANFOSSI G.
Proteina C-reattiva: dosare o non dosare nel paziente diabetico
2005-01-01 TROVATI M; ANFOSSI G
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance
2004-01-01 DORONZO G.; RUSSO I.; MATTIELLO L.; ANFOSSI G.; BOSIA A.; TROVATI M.
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity
2004-01-01 ANFOSSI G.; RUSSO I.; MASSUCCO P.; MATTIELLO L.; DORONZO G.; DE SALVE A.; TROVATI M.
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits
2004-01-01 ANFOSSI G; MASSUCCO P; BONOMO K; TROVATI M.
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents
2004-01-01 RUSSO I; DORONZO G; MATTIELLO L; DE SALVE A; TROVATI M; ANFOSSI G.
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects.
2003-01-01 G. ANFOSSI; RUSSO I.; MASSUCCO P.; MATTIELLO L.; TROVATI M.
Comparison between the effects of the rapid recombinant insulin analog LYSPRO (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation
2003-01-01 RUSSO I; MASSUCCO P; MASSUCCO P.; CAVALOT F.; ANFOSSI G.; TROVATI M.
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells
2003-01-01 BERGANDI L; SILVAGNO F; RUSSO I; RIGANTI C; ANFOSSI G; ALDIERI E; GHIGO D; TROVATI M; BOSIA A
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets.
2002-01-01 ANFOSSI G; RUSSO I; MASSUCCO P; MATTIELLO L; M. TROVATI
White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes
2002-01-01 CAVALOT F; MASSUCCO P; PERNA P; TRAVERSA M; G. ANFOSSI; TROVATI M
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation.
2002-01-01 RUSSO I; MASSUCCO P; MATTIELLO L.; CAVALOT F.; G. ANFOSSI; TROVATI M.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile